Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients

Abstract

Treatment of AR with FP significantly reduces the levels of cys-LTs, major noninvasive markers of lower airway inflammation, suggesting that upper and lower airway inflammation is present and should be thus treated as a whole in subjects with AR with and without asthma.